 ANAHEIM, CA, Sept. 22, 2021 GLOBE NEWSWIRE -- via NewMediaWire -- BioCorRx Inc. OTCQB: BICX the Company, a developer and provider of advanced solutions in the treatment of substance use disorders, announced today that it has filed a patent application with the U.S. Patent and Trademark Office USPTO for a biodegradable implant including naltrexone. Several of the claims in the application are intended to cover BICX104, an implantable biodegradable naltrexone pellet for the treatment of opioid use disorder OUD, being developed under BioCorRx Pharmaceuticals, Inc., the Companys controlled RD subsidiary. 